4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-206540
Chief Executive Officer sold 40,000 shares at $50.10 ($2,003,860)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BELANOFF JOSEPH K Chief Executive Officer | 2026-05-01 | Sale 10b5-1 | −40,000 | $50.10 | $2,003,860 | 2,878,326 | I |
| Open-market sales · 40,000 sh · avg $50.10 · $2,003,860 | |||||||
Loading xslF345X06/ownership.xml…